The optimal prediction results were achieved using age, baseline NIHSS, blood glucose and hematocrit levels, sex, presence of atrial fibrillation, hypertension, and hyperlipidemia, treatment decision (endovascular thrombectomy or tissue plasminogen activator), symptom onset to admission time, and blood pressure as features. This evidence concerns the gene PLAT and hypertensive disorder.